Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence
Polish Archives of Internal Medicine · 2024
DOI: 10.20452/pamw.16659 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polish Archives of Internal Medicine, 2024. Verfasst von Carlo Covello und 5 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, Centro di Malattie dell’Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli I…. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Sarcopenia, Inflammatory Bowel Diseases, Malnutrition. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
There is an increasing interest in using popular diets to manage inflammatory bowel diseases (IBDs), such as ulcerative colitis and Crohn disease. These conditions are often associated with nutritional deficiencies, protein‑energy malnutrition, micronutrient malnutrition, altered body composition, and sarcopenia. While dietary interventions can be supportive in treating intestinal symptoms of adult IBD patients, it is important to note that current guidelines from major scientific societies do not recommend any specific dietary interventions in this field. This review aims to provide a summary of the current evidence on dietary‑nutritional management for patients with IBD, specifically when the disease appears to be in remission, but the patient continues to experience irritable bowel syndrome (IBS) symptoms or functional gastrointestinal symptoms. We focus on vital aspects, such as malnutrition and sarcopenia definitions, screening, and nutritional assessment. We then discuss in detail the most popular diets used for IBD management over the years, characterizing each one in terms of effects on gut inflammation, IBS‑like symptoms, and potential risk of malnutrition. These diets include a low‑fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet, a gluten‑free diet, a Mediterranean diet, and a plant‑based diet. To date, current evidence does not conclusively establish the optimal diet for patients with IBS, suggesting that personalized dietary approaches may be the best strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- IBD Unit, Centro di Malattie dell’Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; IBD Unit, Centro di Malattie dell’Apparato Digerent…
- UOC di Nutrizione Clinica, Dipartimento Scienze Mediche e Chirurgiche Addominali ed Endocrino-Metaboliche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
- IBD Unit, Centro di Malattie dell’Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy
Zitieren
APA
Covello, C., Becherucci, G., Scaldaferri, F., Laterza, L., Gasbarrini, A., & Mentella, M. C. (2024). Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence. Polish Archives of Internal Medicine. https://doi.org/10.20452/pamw.16659
Vancouver
Covello C, Becherucci G, Scaldaferri F, Laterza L, Gasbarrini A, Mentella MC. Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence. Polish Archives of Internal Medicine. 2024. doi:10.20452/pamw.16659
BibTeX
@article{Covello2024,
author = {Covello, Carlo and Becherucci, Guia and Scaldaferri, Franco and Laterza, Lucrezia and Gasbarrini, Antonio and Mentella, Maria C},
title = {Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence},
journal = {Polish Archives of Internal Medicine},
year = {2024},
doi = {10.20452/pamw.16659}
}
EUVIMED